Phathom Pharmaceuticals Competitors and Similar CompaniesClear all
Phathom Pharmaceuticals's competitors and similar companies include Restech, Immatics, AM Pharma and Juvenescence.
 Phathom Pharmaceuticals Phathom Pharmaceuticals is a biopharmaceutical company focused on treating gastrointestinal diseases and disorders. |  Restech Restech is a digestive health solutions company that offers minimally invasive tools to multiple specialties in order to diagnose and manage reflux. |  Immatics Immatics is a biotechnology company that is primarily engaged in the research and development of T cell redirecting immunotherapies for the treatment of cancer. |  Juvenescence Juvenescence is a biotech longevity company that develops therapies and products targeting aging.
| ||
Founding Date | Founding Date 2018 | Founding Date 2003 | Founding Date N/A | Founding Date 2001 | Founding Date 2016 |
Type | Type Public | Type Private | Type Public | Type Private | Type Private |
Tags | |||||
Locations | Locations Buffalo Grove, US HQ Florham Park, US Menlo Park, US | Locations Houston, US HQ | Locations Tübingen, DE HQ Frankfurt Am Main, DE München, DE Houston, US | Locations Utrecht, NL HQ Utrecht, NL | Locations Dublin, IE HQ |
Employees | Employees 1633% increase | Employees 783% decrease | Employees 29723% increase | Employees 28 | Employees 3310% increase |
Valuation ($) | Valuation ($) 1.2 b | Valuation ($) N/A | Valuation ($) 1.1 b | Valuation ($) N/A | Valuation ($) 500 m |
Financial | |||||
Revenue (est.) | Revenue (est.) $175.1m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) €48.3m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods $22.6m (FY, 2025) | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit $152.5m (FY, 2025) | Gross profit N/A | Gross profit €53m (FY, 2025) | Gross profit N/A | Gross profit N/A |
Net income | Net income ($221.2m) (FY, 2025) | Net income N/A | Net income (€196.4m) (FY, 2025) | Net income N/A | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 24m (about 6 years ago) | Latest funding round $ 100m (almost 7 years ago) |
Total funding raised | Total funding raised $ 140m | Total funding raised N/A | Total funding raised $ 267.3m | Total funding raised $ 210.3m | Total funding raised $ 162.3m |
For sources of this data, please see the company profile
View Company Profiles
Restech
HQ
Houston, US
Employees
78↓ 3% decrease
Restech is a digestive health solutions company that offers minimally invasive tools to multiple specialties in order to diagnose and manage reflux.
View companyImmatics
HQ
Tübingen, DE
Employees
297↑ 23% increase
Immatics is a biotechnology company that is primarily engaged in the research and development of T cell redirecting immunotherapies for the treatment of cancer.
View company
AM Pharma
HQ
Utrecht, NL
Employees
28
AM-Pharma is a biopharmaceutical company that develops medicines for patients.
View companyJuvenescence
HQ
Dublin, IE
Employees
33↑ 10% increase
Juvenescence is a biotech longevity company that develops therapies and products targeting aging.
View company